Addex Therapeutics (ADXN)

Addex Therapeutics (ADXN) Financial Statements


Addex Therapeutics Financial Overview

Addex Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.367; its P/E ratio is -0.30; Addex Therapeutics is scheduled to report earnings on August 7, 2023, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-SFr. 409.42KSFr. 183.35KSFr. 237.24KSFr. 397.49K
Gross Profit-----
EBIT-SFr. -4.10MSFr. -7.21MSFr. -5.76MSFr. -4.41M
EBITDA-SFr. -4.02MSFr. -7.13MSFr. -5.68MSFr. -4.33M
Net Income Common Stockholders-SFr. -4.11MSFr. -7.22MSFr. -5.82MSFr. -4.42M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsSFr. 6.96MSFr. 10.43MSFr. 8.82MSFr. 14.90MSFr. 20.50M
Total AssetsSFr. 8.28MSFr. 12.24MSFr. 11.38MSFr. 17.68MSFr. 22.54M
Total DebtSFr. 373.13KSFr. 447.11KSFr. 336.95KSFr. 412.87KSFr. 482.01K
Net DebtSFr. -6.58MSFr. -9.98MSFr. -8.48MSFr. -14.48MSFr. -20.02M
Total LiabilitiesSFr. 30.29MSFr. 4.29MSFr. 4.52MSFr. 4.73MSFr. 5.61M
Stockholders EquitySFr. -22.03MSFr. 7.95MSFr. 6.86MSFr. 12.96MSFr. 16.93M
Cash Flow-
Free Cash Flow-SFr. -2.69MSFr. -5.83MSFr. -4.84MSFr. -2.97M
Operating Cash Flow-SFr. -2.69MSFr. -5.83MSFr. -4.84MSFr. -2.94M
Investing Cash Flow-SFr. 2.98KSFr. 0.00SFr. 0.00SFr. -24.40K
Financing Cash Flow-SFr. 4.19MSFr. -170.25KSFr. -744.35KSFr. 8.16M
Currency in CHF

Addex Therapeutics Earnings and Revenue History

Addex Therapeutics Debt to Assets

Addex Therapeutics Cash Flow

Addex Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis